A lymphotoxin-driven pathway to hepatocellular carcinoma. - Test2 - elhamkhani - TriplyDB

A lymphotoxin-driven pathway to hepatocellular carcinoma.

A lymphotoxin-driven pathway to hepatocellular carcinoma.

http://www.wikidata.org/entity/Q35575883

about

Immunopositivity for histone macroH2A1 isoforms marks steatosis-associated hepatocellular carcinoma Galectin-9 functionally impairs natural killer cells in humans and mice Tissue- and Serum-Associated Biomarkers of Hepatocellular Carcinoma Therapeutic Lymphoid Organogenesis in the Tumor Microenvironment HBV induced HCC: major risk factors from genetic to molecular level Smad3 phospho-isoform signaling in hepatitis C virus-related chronic liver diseases Hepatitis B: future curative strategies Viruses in cancer cell plasticity: the role of hepatitis C virus in hepatocellular carcinoma Lymphotoxin signaling is initiated by the viral polymerase in HCV-linked tumorigenesis Immunity, Inflammation, and Cancer Damage-associated molecular patterns in cancer: a double-edged sword Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis Insights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic intervention Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms Inflammation- and stress-related signaling pathways in hepatocarcinogenesis NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis Superior antitumoral activity of dimerized targeted single-chain TRAIL fusion proteins under retention of tumor selectivity Interference with oligomerization and glycosaminoglycan binding of the chemokine CCL5 improves experimental liver injury Inflammation meets cancer, with NF-κB as the matchmaker LIGHT induces distinct signals to clear an AAV-expressed persistent antigen in the mouse liver and to induce liver inflammation.B1, a novel HDAC inhibitor, induces apoptosis through the regulation of STAT3 and NF-κB.Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation TNFα cooperates with IFN-γ to repress Bcl-xL expression to sensitize metastatic colon carcinoma cells to TRAIL-mediated apoptosis.Heat shock protein 70 serum levels differ significantly in patients with chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.Recombinant VP1, an Akt inhibitor, suppresses progression of hepatocellular carcinoma by inducing apoptosis and modulation of CCL2 production Cancer gene discovery in hepatocellular carcinoma Polymorphic variants of LIGHT (TNF superfamily-14) alter receptor avidity and bioavailability.Direct and indirect roles of the LTbetaR pathway in central tolerance induction.Hepatocyte-specific deletion of the antiapoptotic protein myeloid cell leukemia-1 triggers proliferation and hepatocarcinogenesis in mice.Sustained virologic response to antiviral therapy for chronic hepatitis C virus infection: a cure and so much more.Lymphotoxin, NF-ĸB, and cancer: the dark side of cytokines.Death receptor-independent FADD signalling triggers hepatitis and hepatocellular carcinoma in mice with liver parenchymal cell-specific NEMO knockout.Genetic deletion of AEG-1 prevents hepatocarcinogenesis.Hepatitis B viral core protein disrupts human host gene expression by binding to promoter regions.Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma.Immune biomarker differences and changes comparing HCV mono-infected, HIV/HCV co-infected, and HCV spontaneously cleared patients.Lymphotoxin β receptor activation promotes bladder cancer in a nuclear factor-κB-dependent manner.Control of the inflammatory response mechanisms mediated by natural and induced regulatory T-cells in HCV-, HTLV-1-, and EBV-associated cancers.

P2860

Q21133747-DDEFB852-BC2C-4E14-9751-A12D530DAE03 Q24317152-DFD30A66-20C5-45DD-A9AD-6D429DAC9A6B Q26743361-5528F137-5427-4B24-83BB-4B6F45B3BAE2 Q26799123-66786D93-8C70-4B25-BCE7-44D0816FCFEA Q26825274-C49B847F-6896-42E3-8B6C-690813785514 Q26863522-356955E9-0AD6-4331-A59E-6089C680AC7F Q27011623-54EABCD3-181B-4284-AA1C-AF0CB3E7B6AD Q27012614-26EDBD64-43C1-4340-8750-01F7AA130446 Q27335708-4E64790B-0B90-4083-B751-D1A2BCB062FF Q27861048-EBE4188D-5C5E-4AEE-BFD3-1396AADB839E Q28067434-E8DCED88-D86E-4BBA-8617-9008017F71A6 Q28075646-6A65BD9B-ACB7-48A4-B724-AEAF7CE9EEC7 Q28080281-0C6FF71F-7C42-4B69-9091-5342733FBBBD Q28272678-2CE7E131-AD14-4CFB-8E22-3B34D544BD3D Q28383729-C9C5B3C7-E3F1-4EC1-B82E-26CDA2E45CCE Q28387669-D576BADD-6958-4210-B87B-500B0EEE9037 Q28593092-C2C3DDEA-7E42-4060-9F12-D4DC57D51DB9 Q28729760-A5C22A5D-2AC2-49BD-85A2-A1C2225F8319 Q28730116-E6265207-D755-4B83-AB01-773C99812EE1 Q29620242-F8CC3D39-AEC4-43DD-9E2A-F9B9933C5E4C Q33586211-52D59430-A1E8-4E68-A569-9428724BFBC0 Q33597695-C196DF39-64D3-4120-9D4D-D379B5BE63B5 Q33737707-D36624EC-50C7-4C16-9C21-41CA78C5C2AB Q33802588-8FF5505C-DF5F-4975-94F3-42F3ADE08343 Q33827475-43F55CE6-CE7E-4070-B491-160B97CB323D Q33904328-245675D8-D744-4A96-9F5F-30F3CBE1911C Q33986185-1EA21A1B-DDBD-4CA4-9B92-38BF8C17CF00 Q34002120-749F4A5A-7DE6-416E-9990-D2737243C22C Q34065607-209FFD07-024E-46E8-8287-5BBE48863A64 Q34103805-A671013B-6588-4EC1-8CB8-9DCDB98316AB Q34117033-7FB2F1BE-F423-4C4E-B19A-FBD72159733B Q34172595-51AB173E-8503-4EDA-A01D-E3D4E76AE4A7 Q34308847-07D7D861-C880-4088-BBAC-D0F52F3FC919 Q34413462-BDB7F93B-659E-494E-9CB1-58DEB6EF06A9 Q34438436-0FB91F36-D81C-4D67-B6D6-39BAA5CFE7E9 Q34454353-47DE6E89-3953-45CF-B032-A02B49502B9C Q34499441-421DCA55-7635-4BA6-AEF9-BB7DC4D6DE96 Q34673075-E1B4ECAF-55BA-4003-A4F4-EC988CEA8957 Q34673313-473B866F-1D2D-43A8-A398-C134E7EF4ACF Q34708248-4FA7282B-1B97-4681-A387-EFDCB1D6A93A

P2860

A lymphotoxin-driven pathway to hepatocellular carcinoma.

http://www.wikidata.org/entity/Q35575883

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

A lymphotoxin-driven pathway to hepatocellular carcinoma.

@ast

A lymphotoxin-driven pathway to hepatocellular carcinoma.

@en

type

label

A lymphotoxin-driven pathway to hepatocellular carcinoma.

@ast

A lymphotoxin-driven pathway to hepatocellular carcinoma.

@en

prefLabel

A lymphotoxin-driven pathway to hepatocellular carcinoma.

@ast

A lymphotoxin-driven pathway to hepatocellular carcinoma.

@en

P1433

Q35575883-E3F64836-0484-41F4-9C17-3A82BA7CA5D1

P1476

Q35575883-787B439C-3166-4C69-A997-54A7B5F1F2F0

P2093

Q35575883-0AE2992D-C8A8-4062-836C-3B7BBFCA717C

Q35575883-0EC96194-63D7-4C88-B44D-DEECFA474FDB

Q35575883-19F8E90A-6BD7-40A8-A8FD-333BFC900324

Q35575883-384AFF83-94AF-4392-94ED-B59DF9DCD736

Q35575883-3C5B7AA1-634D-47A8-B0D5-7AF397FD5EC1

Q35575883-5588447C-FC8C-46B4-9FF5-FCBB0E8B2F2F

Q35575883-590F4AA9-06DA-46D2-A156-8AB7766C6F46

Q35575883-60B45C19-8D70-46DE-B9FA-D8D4D8DE4087

Q35575883-7F84A5FB-74B2-466C-BCCA-5B7481FC291B

Q35575883-9C24D069-5678-465B-8AF0-F921EA487200

P2860

Q35575883-02A5A460-0676-4D33-9501-7CDE59C9BE76

Q35575883-08830AA1-13B0-471E-B817-D9EEE75D89FB

Q35575883-0A1CF230-DBAD-476A-A688-EB59CFB411BF

Q35575883-1FB1E51B-63B5-4304-B849-DED80BB65A12

Q35575883-20C1321D-6D18-4452-B6F5-A97273D8872C

Q35575883-23E144C6-2BFA-48E2-B37E-9CA166A77830

Q35575883-271F7616-4CEB-40FF-96FD-D362F2F7A94F

Q35575883-28BF4157-8647-4081-B0A9-3A726CC5A687

Q35575883-2A198A42-AB7C-463A-8F9E-87FE623F7435

Q35575883-2E966F01-8C3D-49CC-A7DF-5C83B81ABF39

P304

Q35575883-2179070C-4107-4BDF-ACBD-5638A81F5046

P31

Q35575883-46B5FC76-FB32-4B63-8EC3-DE2624911BDD

P356

Q35575883-F567D65A-3332-4C8D-AA01-E7BA9B24888C

P433

Q35575883-4481AD07-00CA-4F9E-92C2-75922F29D29A

P478

Q35575883-64B457DD-2B3B-4ED4-8CA1-A7DADADF6A65

P50

Q35575883-04877352-2892-4523-ACAD-F446FEDC8EA0

Q35575883-2856831B-2F64-4CE6-BD90-88E8B8BF9F5C

Q35575883-2C3DBA09-E4D2-40E6-9065-8EB88B33C2A7

Q35575883-40FD5388-E0D1-4129-9F4F-B4D21ED42528

Q35575883-47479D7D-D271-419E-8F11-A1391257B4E6

Q35575883-4FEBCDCB-2062-4CF6-A743-AA9AD2A42996

Q35575883-7C8C623A-36A5-49B7-9AFB-D7725AEE38A6

Q35575883-B6EE7BFF-1DEF-4A9A-B597-72E07E65E6D8

Q35575883-EA9FEA82-AA1D-4BA7-B896-B90F669A314D

P577

Q35575883-91F91C69-A830-4916-9F2C-9DBB18B24D05

P5875

Q35575883-78A99C18-DDD8-466F-B2B1-BA546DE0F534

P698

Q35575883-908D584F-248C-4ABE-82DA-50A82DC2DAE9

P932

Q35575883-A4BA2965-EEED-4BF7-AA79-BF58368993D2

P356

J.CCR.2009.08.021

P1433

P1476

A lymphotoxin-driven pathway to hepatocellular carcinoma.

@en

P2093

Achim Weber

http://www.w3.org/2001/XMLSchema#string

Giandomenica Iezzi

http://www.w3.org/2001/XMLSchema#string

Hubert Blum

http://www.w3.org/2001/XMLSchema#string

Johannes Haybaeck

http://www.w3.org/2001/XMLSchema#string

Juliane Bremer

http://www.w3.org/2001/XMLSchema#string

Michael Odo Kurrer

http://www.w3.org/2001/XMLSchema#string

Monika Julia Wolf

http://www.w3.org/2001/XMLSchema#string

Muhammad Ramzan

http://www.w3.org/2001/XMLSchema#string

Nicolas Zeller

http://www.w3.org/2001/XMLSchema#string

Robert Thimme

http://www.w3.org/2001/XMLSchema#string

P2860

PH domain-only protein PHLDA3 is a p53-regulated repressor of Akt

Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor

Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis.

Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication.

Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras

Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development

RAG-1-deficient mice have no mature B and T lymphocytes

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

P304

295-308

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CCR.2009.08.021

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Patrice N. Marche

Jeffrey L. Browning

Pierre-Alain Clavien

Mathias Heikenwalder

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26866857

http://www.w3.org/2001/XMLSchema#string

P698

19800575

http://www.w3.org/2001/XMLSchema#string

P932

4422166

http://www.w3.org/2001/XMLSchema#string